Cornell University Gets FDA Grant to Track Antibiotic Use in Animals

Cornell University researchers received a $7.5 million grant from the U.S. Food and Drug Administration to build a new system for tracking antibiotic use in animals.

Vet Candy reported that the five-year initiative aims to close major gaps in veterinary medicine. Antimicrobial resistance threatens both human and animal health when bacteria survive exposure to drugs designed to kill them.

Existing monitoring systems rely heavily on pharmaceutical sales data rather than actual clinical administration. Renata Ivanek, DVM, PhD, a professor of population medicine and diagnostic sciences at Cornell University’s College of Veterinary Medicine, leads the new project.

“The project addresses a longstanding challenge in veterinary medicine,” Vet Candy reported, noting that the United States currently lacks a coordinated national tracking system across veterinary sectors.

Cornell University Secures FDA Funding for Veterinary Research

  • Cornell University secured $7.5 million from the FDA for a five-year veterinary research initiative.
  • The project initially targets dairy cattle, poultry, and companion animals to build a secure data-sharing platform.
  • Researchers plan to protect the privacy of farmers and veterinarians while standardizing antimicrobial use measurements.

Developing Standardized Metrics Across Veterinary Sectors

The new research initiative will focus initially on dairy cattle, poultry, and companion animals. Researchers plan to explore expanding the system into beef cattle and swine production.

A central obstacle in veterinary medicine involves disparate measurement techniques. Some systems report the total weight of ingredients, while others track specific treatment doses or veterinary visits.

Ivanek and her collaborators intend to establish consistent metrics to evaluate differences among production systems and geographic regions. A unified system could help separate changes driven by disease outbreaks from shifts in routine prescribing practices.

Pharmaceutical sales figures often fail to reflect actual clinical use. Medications can be purchased and stored without immediate administration, leaving regulators with an incomplete picture of prescribing habits.

Protecting Participant Privacy in Data Collection

Reluctance to participate in tracking programs stems largely from privacy concerns. Veterinarians and livestock producers worry that prescribing statistics might be judged without adequate clinical context.

Higher antibiotic use does not automatically indicate poor stewardship. Clinics treating critically ill patients or farms managing active disease outbreaks naturally require different treatment strategies.

To encourage participation, researchers plan to develop privacy-preserving technology. Information will be analyzed at its original source, aggregating data locally before transmitting summarized results.

The team also intends to establish governance procedures with input from stakeholders. These protocols will address questions regarding data access, security, and appropriate use.

Building a Digital Dashboard for Industry Benchmarks

Another planned component involves a digital dashboard for authorized participants. Veterinarians and animal producers could review aggregated information to compare their prescribing patterns with broader benchmarks.

Companion animal practices might evaluate antibiotic use across common clinical conditions. Livestock veterinarians could assess antimicrobial use within different production systems.

The research team must account for variables like patient population, disease severity, and clinical outcomes before comparisons can reliably inform treatment decisions. The proposed dashboard remains a development goal rather than an active clinical tool.

Cornell has not announced a date for when the dashboard might become available. Additional work is required to determine which measurements provide meaningful comparisons across species.

Project Detail Specification
Funding Amount $7.5 million
Grant Agency U.S. Food and Drug Administration
Initiative Duration Five years
Lead Researcher Renata Ivanek, DVM, PhD
Initial Focus Sectors Dairy cattle, poultry, companion animals

Connecting Animal Health Through One Health

The initiative ties into the broader One Health approach, recognizing connections between human, animal, and environmental health. Resistant bacteria can move across these systems through direct contact, food production, and environmental contamination.

Improved data will help scientists investigate relationships between veterinary prescribing and resistance patterns. However, the project will not independently predict or prevent resistant infections.

Co-principal investigators Daryl Nydam and Casey Cazer from Cornell’s College of Veterinary Medicine join faculty from the College of Agriculture and Life Sciences and Cornell Bowers Computing and Information Science on the project.

External collaborators include Randall Singer of Mindwalk Consulting Group and Jennifer Granick of the University of Minnesota. The research team will continue developing the monitoring standards over the five-year initiative.

Photo of author

Marina Collins - Entertainment Editor

Senior Editor, Entertainment Marina is a celebrated pop culture columnist and recipient of multiple media awards. She curates engaging stories about film, music, television, and celebrity news, always with a fresh and authoritative voice.

Tadej Pogačar Attends Eddie Dunbar’s Wedding in Ireland

Is Trading Options Academy Worth It? A Complete Review of TOA Plans & Pricing